Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 12, 2009, Pages 1907-1913

  Kumar, Nicola ^a   Dahri, Lynn ^a   Brown, Wendy ^a   Duncan, Neill ^a   Singh, Seema ^a   Baker, Christopher ^b   Malik, Iqbal ^b   Palmer, Andrew ^a   Griffith, Megan ^a   Cairns, Tom ^a   Taube, David ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTILIPEMIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IODIXANOL; IOHEXOL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY DISEASE; DIALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SAFETY; RENAL PROTECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST; TREND STUDY;

AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WAITING LISTS;

EID: 73649124550     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01480209     Document Type: Article

References (24)

1. Herzog C: How to manage the renal patient with coronary heart disease: The agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 14: 2556-2572, 2003
2. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK: Long-term survival in renal transplant recipients with graft function. Kidney Int 57: 307-313, 2000
3. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105: 2259-2264, 2002
4. Fung JW, Szeto CC, Chan WW, Kum LC, Chan AK, Wong JT, Wu EB, Yip GW, Chan JY, Cheuk YU, Woo KS, Sanderson JE: Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: A randomised trial. Am J Kidney Dis 43: 801-808, 2004
5. Gami AS, Garovic VD: Contrast nephropathy after coronary angiography. Mayo Clin Proc 79: 211-219, 2004
6. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, Van-Fossen DB: Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: A randomised trial. Kidney Int 47: 254-261, 1995
7. Pichard AD, Satler LF, Leon MB: The prognostic implications of further renal function deterioration within 48 hours of interval coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36: 1542-1548, 2000
8. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: Incidence, risk factors and relationship to mortality. Am J Med 103: 368-375, 1997
9. Berns AS: Nephrotoxicity of contrast media. Kidney Int 36: 730-740, 1989
10. Pucelikova T, Dangas G, Mehran R: Contrast-induced nephropathy. Catheter Cardiovasc Interv 71: 62-72, 2008
11. Meier-Kriesche H, Schold JD, Srinivas TR, Reed A, Kaplan B: Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplantation 4: 1662-1668, 2004
12. Statistics and Audit Directorate UK Transplant. Transplant Activity in the UK 2006-2007:18
13. Hirshfield J: Invasive cardiovascular procedures - Optimizing patient safety. New En Journ Med 349:1311-1312, 2003
14. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli L: The Prevention of radio contrast-agent-Induced nephropathy by hemofiltration. N Engl J Med 349:1333-1340, 2003
15. Katholi RE, Wood WT, Taylor GJ, Dietrick CL, Womack KA, Katholi CR, McCann WP: Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 32: 64-71, 1998
16. Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L: Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6: 1451-1458, 1995
17. Kane G, Doyle B, Lerman A, Barness G, Best P, Rihal C: Ultra-low contrast volumes reduce rates of contrast induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. Journ Am Coll of Cardiol 51: 89-90, 2008
18. Bashore TM, Gehrig T: Cholesterol emboli after invasive cardiac procedures. J Am Coll Cardiol 42: 217-218, 2003
19. Saklayen MG, Gupta S, Suryaprasad A, Azmeh W: Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Angiology 48: 609-613, 1997
20. Tadros GM, Malik JA, Manske CL, Kasiske BL, Dickinson SE, Herzog CA, Wilson RF, Das G, Panetta CJ: Iso-osmolar radiocontrast Iodixanol in patients with chronic kidney disease. J Invasive Cardiol 4: 499e1-499e8, 2005
21. Jo S, Koo B, Park J, Kang H, Cho Y, Kim Y, Youn TJ, Chung WY, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS: Prevention of radio contrast medium-induced nephropathy using short term high dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial - A randomized control study. Am Heart J 155: 499e1-499e8, 2008
22. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Kristensen SD, Widimsky P, McGregor K, Sechtem U, Tendera M, Hellemans I, Gomez JL, Silber S, Funck-Brentano C, Kristensen SD, Andreotti F, Benzer W, Bertrand M, Betriu A, De Caterina R, DeSutter J, Falk V, Ortiz AF, Gitt A, Hasin Y, Huber K, Kornowski R, Lopez-Sendon J, Morais J, Nordrehaug JE, Silber S, Steg PG, Thygesen K, Tubaro M, Turpie AG, Verheugt F, Windecker S; ESC Committee for Practice Guidelines (CPG): Guidelines for the diagnosis, treatment of non-ST-segment elevation acute coronary syndromes: The task force for the diagnosis, treatment of non-ST-segment elevation acute coronary syndromes of the European society of cardiology. Eur Heart J: 28:1598-1660, 2007
23. Boden WE, O'Rouke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini J, Weintraub WS, for the COURAGE Trial Research Group: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356: 1503-1516, 2007
24. Patel RK, Mark PB, Johnston N, McGeoch R, Lindsay M, Kingsmore DB, Dargie HJ, Jardine AG: Prognostic value of cardiovascular screening in potential renal transplant recipients: A single-centre prospective observational study. Am J Transplant 8: 1673-1683, 2008